Toward a Pharmaceutical Anthropology in Morocco: The Biography of Aureomycin from Physical Production to Cultural Reinterpretation

المؤلفون

  • المؤلف

  • Farouk Tahri

الكلمات المفتاحية:

Pharmaceutical Anthropology، Biography of Medicine، Aureomycin، Morocco، Folk Remedies

الملخص

Pharmaceutical anthropology calls for moving beyond the conventional divide between folk remedies and modern pharmaceuticals and applying the same analytical lens to both. The biographical approach to objects helps to understand the various transformations and interactions that govern a medicine within a specific context. This study traces the life story of Aureomycin in Morocco from its initial introduction, through physical production, marketing, and distribution, to consumption. It shows that the medicine had not been used as its producers had anticipate. It has rather been subject to the logic of “pharmaceutical heretics” who treat Aureomycin as a folk remedy and integrate it into a new, intermediary treatment process that is neither fully modern nor wholly traditional.

المراجع

  1. David Zeitlyn, “Life-History Writing and the Anthropological Silhouette,” Social Anthropology/Anthropologie Sociale , vol. 16, no. 2 (2008), p. 167.
  2. Igor Kopytoff, “The Cultural Biography of Things: Commoditization as Process,” in: Arjun Appadurai (ed.), The Social Life of Things: Commodities in Cultural Perspective (Cambridge: Cambridge University Press, 2013), p. 65.
  3. Diarmuid Jeffries, The Remarkable Story of a Wonder Drug (Philadelphia: Chemical Heritage Foundation, 2008).
  4. David Cohen et al., “Medications as Social Phenomena,” Health , vol. 5, no. 4 (2001), pp. 448-449.
  5. Sjaak van der Geest, Susan Reynolds Whyte & Anita Hardon, “The Anthropology of Pharmaceuticals: A Biographical Approach,” Annual Review of Anthropology , vol. 25 (1996), p. 156.
  6. Sjaak van der Geest & Kerry Chamberlain, “Researching the Life Stages of Medicines,” Medische Antropologie: Journal about Culture and Health , vol. 23, no. 2 (2011), p. 232.
  7. Sjaak van der Geest, “Anthropology and the Pharmaceutical Nexus,” Anthropology Quarterly , vol. 79, no. 2 (Spring 2006), p. 307.
  8. Anne M. Lovell, “Addiction Markets: The Case of High-Dose Buprenorphine in France,” in: Adriana Petryna, Andrew Lakoff & Arthur Kleinman (eds.), Global Pharmaceuticals: Ethics, Markets, Practices (Durham, NC: Duke University Press, 2006), pp. 155-156.
  9. Geest & Chamberlain, p. 234.
  10. Bujumaa Ruyan, al-Ṭibb al-Kūlūnyālī al-Faransī bi-l-Maghrib 1912 - 19 45 (Rabat: Manshurat al-Ribat.net, 2020), p. 264.
  11. Edward Westermarck, Ritual and Belief in Morocco , vol. II (New York: University Books Inc, 1968), p. 13.
  12. J. Reinhards et al., “Studies in the Epidemiology and Control of Seasonal Conjunctivitis and Trachoma in Southern Morocco,” Bulletin of the World Health Organization , vol. 39, no. 4 (1968), pp. 499-500.
  13. Gian Battista Bietti, “Progrès de la chimiothérapie et de l'antibiothérapie du trachome: Épreuves d'efficacité, nouveaux produits, traitement intermittent,” Bulletin of the World Health Organization , vol. 28, no. 4 (1963), p. 401.
  14. Reinhards et al., p. 525.
  15. J. Reinhards, A. Weber & F. Maxwell-Lyons, “Collective Antibiotic Treatment of Trachoma: Report on Comparative Trials Leading to More Economic Methods of Treatment,” Bulletin of the World Health Organization , vol. 21, no. 6 (1959), p. 699.
  16. Geest & Chamberlain, p. 234.
  17. Thomas H. Jukes, “Some Historical Notes on Chlortetracycline,” Reviews of Infectious Diseases , vol. 7, no. 5 (1985), pp. 702-703.
  18. Benjamin Duggar, “Aureomycin: A Product of the Continuing Search for New Antibiotics,” Annals of the New York Academy of Sciences , vol. 51, no. 2 (1948), pp. 177-181.
  19. André Frogerais, “Les origines de la fabrication des antibiotiques en France,” Hal Open Science (2015), p. 20.
  20. Arthur Joseph Boase, “Aureomycin in Trachoma,” The British Journal of Ophthalmology , vol. 34, no. 10 (1950), p. 627.
  21. Ibid., pp. 631-632.
  22. Stewart Duke-Elder, Derek Ainslie & Arthur James Boase, “Aureomycin in Ophthalmology: A Preliminary Report,” The British Journal of Ophthalmology , vol. 34, no. 1 (1950), p. 30.
  23. Toulant et al., “Essais de traitement du trachome par l'auréomycine et la chloromycétine,” Bulletin de L'académie Nationale de Médecine , vol. 135, no. 5-6 (1951), p. 81.
  24. Renald Ching, “Aureomycin in the Treatment of Trachoma,” AMA Archives of Ophthalmology , vol. 45, no. 6 (1951), p. 659.
  25. Reinhards et al., p. 525.
  26. Paul Rabinow, Making PCR: A Story of Biotechnology (Chicago: The University of Chicago Press, 1996), p. 10.
  27. Geest & Chamberlain, p. 231.
  28. Kopytoff, p. 68.
  29. Susan Reynolds Whyte & Sjaak van der Geest (eds.), The Context of Medicines in Developing Countries: Studies in Pharmaceutical Anthropology (Dordrecht: Springer Netherlands, 1988), p. 4.
  30. Cohen et al., p. 449.
  31. “The Treatment of Trachoma,” Medical Journal of Australia , vol. 1, no. 25 (June 1960), p. 984.
  32. Reinhards et al., p. 523.
  33. Nina L. Etkin, Paul J. Ross & Ibrahim Muazzamu, “The Indigenization of Pharmaceuticals: Therapeutic Transitions in Rural Hausaland,” Social Science and Medicine , vol. 30, no. 8 (1990), p. 919.
  34. Hicham Nhaili, “La législation pharmaceutique au Maroc durant le protectorat Français (1912-1956),” PhD. Dissertation, Université Mohammed V, Faculté de Médecine et de Pharmacie, Rabat, 2014, p. 72.
  35. Hilbrand Haak & Anita P. Hardon, “Indigenised Pharmaceuticals in Developing Countries: Widely Used, Widely Neglected,” The Lancet , vol. 332, no. 8611 (1988), p. 621.
  36. Ruyan, pp. 350-351.
  37. Reinhards et al., p. 538.
  38. Farouk Tahri, “al-Ṭibb al-Ḥayawī bi-Waṣfihi Ṭibban Shaʿbiyyan Ladā l-Marḍā al-Nafsiyyīn wa-ʿĀʾilātihim: Dirāsa fī Iʿādat Intāj al-Waṣfāt al-Ṭibbiyya Khārij al-Mustashfā fī al-Maghrib,” Omran , vol. 12, no. 48 (Spring 2024), p. 41.
  39. Ibid., pp. 41-42.
  40. Etkin, Ross & Muazzamu, p. 923.
  41. “Pharmaceutical Revival Company in Morocco,” Maʿlūmāt Mubāshir , accessed on 7/8/2024, at: https://acr.ps/1L9zRqE
  42. This was confirmed to the researcher personally.
  43. Donald Goldsmith (ed.), Scientists Confront Velikovsky , Isaac Asimov (fore.) (New York: W. W. Norton Company, 1979), p. 7.
  44. C.H. Bledsoe & M.F. Goubaud, “The Reinterpretation of Western Pharmaceuticals among the Mende of Sierra Leone,” Social Science and Medicine , vol. 21, no. 3 (1985), pp. 258.
  45. Susan R. Whyte, “Pharmaceuticals as Folk Medicine: Transformations in the Social Relations of Health Care in Uganda,” Culture, Medicine and Psychiatry , vol. 16, no. 2 (1992), p. 173.
  46. Cohen et al., p. 445.
  47. An Arabization of the French word pommade , this word is used in Morocco to refer to any viscous ointment that can be rubbed onto the skin for curative purposes.
  48. Bledose & Goubard, p. 267.
  49. Sjaak van der Geest & Susan Reynolds Whyte, “The Charm of Medicines: Metaphors and Metonyms,” Medical Anthropology Quarterly , New Series, vol. 3, no. 4 (December 1989), p. 352.
  50. Haak & Hardon, p. 621.
  51. Mahjuba Qawqaw, “al-Mujtamaʿ al-Iftirāḍī wa-Ishkāliyyat Tajdīd Manhaj al-Baḥth al-Sūsyūlūjī: Naḥw Bināʾ Namūdhaj li-Dirāsat al-Tafāʿulāt al- Iliktrūnīyya bi-Wāsiṭat al-Ḥāsūb,” Omran , vol. 8, no. 29 (Summer 2019), p. 94.
  52. Christine Hine, “Ethnographies of Online Communities and Social Media: Modes, Varieties, Affordances,” in: Nigel G. Fieldinget, Raymond M. Lee & Grant Blank (eds.), The SAGE Handbook of Online Research Methods (California: Sage Publications, 2017), p. 412.
  53. Mahjuba Qawqaw, “al-Nitnūghrāfiyā Manhajan li-l-Baḥth al-Sūsiyūlūjī wa-l-Anthrūbūlūjī: Min al-Mulāḥaẓa al-Iliktrūniyya ilā Iʿādat Kitābat al- Athar al-Raqmī,” African Social Dynamics: The African Journal of the Human and Social Sciences , no. 5 (2023), p. 24.
  54. Ibid., p. 29. Source: Prepared by the author.
  55. Qawqaw, “al-Mujtamaʿ al-Iftirāḍī wa-Ishkāliyyat Tajdīd Manhaj al-Baḥth al-Sūsyūlūjī,” p. 98.
  56. “Muqāwamat al-Muḍāḍḍāt al-Ḥayawiyya,” World Health Organization , 31/7/2020, accessed on 10/5/2024, at: https://bit.ly/4b5XfGo
  57. Rajoua Channel, YouTube, 22/4/2019, accessed on 7/8/2024, at: https://bit.ly/4k3Q1Hm
  58. Khadiju Buyuti, YouTube, 7/6/2021, accessed on 7/8/2024, at: https://bit.ly/410Wb24
  59. Ivan Wolffers, “Traditional Practitioners and Western Pharmaceuticals in Sri Lanka,” in: Whyte & Geest (eds.), p. 47.
  60. ʿĀlam Ajmal al-Nisāʾ, YouTube, 26/2/2022, accessed on 7/8/2024, at: https://bit.ly/414FPpi
  61. Bledose & Goubaud, p. 263.
  62. Moroccan Women’s Beauty Secrets, YouTube, 8/11/2022, accessed on 7/8/2024, at: https://bit.ly/3EIG5Tp
  63. Bledose & Goubaud, p. 264.
  64. Moroccan Women’s Beauty Secrets, YouTube, 11/10/2021, accessed on 7/8/2024, at: https://bit.ly/4b7B6rA
  65. Linda K. Sussman, “The Use of Herbal and Biomedical Pharmaceuticals on Mauritius,” in: Whyte & Geest (eds.), p. 206.
  66. Moroccan Women’s Beauty Secrets, YouTube, 25/7/2020, accessed on 11/11/2024, at: https://acr.ps/1L9zRPw
  67. Bledose & Goubaud, p. 277.
  68. Vuk Stambolovic, “Medical Heresy – The View of a Heretic,” Social Science and Medicine , vol. 43, no. 5 (1996), p. 602.
  69. Kopytoff, p. 69.
  70. Ibid., p. 75. Terminal consumption has been defined as the act of acquiring and possessing material goods purely as an end, rather than as a means to achieve true well-being.
  71. Whyte & Geest (eds.), p. 5.
  72. Geest & Whyte, p. 348.
  73. Haak & Hardon, pp. 620-621.
  74. Akile Gürsoy, “Beyond the Orthodox: Heresy in Medicine and the Social Sciences from a Cross-Cultural Perspective,” Social Science and Medicine , vol. 43, no. 5 (1996), p. 580.
  75. Stambolovic, p. 601.
  76. Cohen et al., p. 455.
  77. Geest, Whyte & Hardon, p. 166.
  78. Stambolovic, p. 602.
Cover of العدد 20, Almuntaqa

التنزيلات

PDF (مستضاف) (الإنجليزية)
HTML (الإنجليزية)

منشور

2025-05-01

إحصاءات الاستخدام

46 مشاهدة 68 تنزيل

إصدار

مجلد 8 عدد 020 (2025): العدد 20

القسم

المقالات

الرخصة

الحقوق الفكرية (c) 2025 المنتقى

Creative Commons License

هذا العمل مرخص بموجب Creative Commons Attribution-NonCommercial 4.0 International License.